LifeVantage Corporation

LFVN

NASDAQ · Packaged Foods

$6.20

At close - Sep 23, 4:00 PM EDT - USD

Market Cap$78M

P/E8.2x

52W High$11.71

Volume75.85K

VCP Research Verdict2026Q3

Operational Pivot Strains Revenue and Margin Stability

LifeVantage faces a challenging transition as its LV360 operational framework coincides with a 25.2% year-over-year revenue contraction in 2026Q3. While the company maintains a conservative debt-to-equity ratio of 0.31, the persistent accumulation of $103.7 mi...

GrowthDecelerating

ProfitabilityStrained

ValuationAttractive

TechnicalsMixed

Explore valuation models

MARKET ACTION

LFVN price & volume

Price trend, volume and key moving averages

Launch Terminal

Loading chart...

Market performance

Price History →

Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return

LFVN+5.22%

S&P 500 (^GSPC)+12.39%

1-Year Return

LFVN-39.55%

S&P 500 (^GSPC)+15.77%

3-Year Return

LFVN+2.91%

S&P 500 (^GSPC)+86.28%

5-Year Return

LFVN+2.96%

S&P 500 (^GSPC)+69.51%

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis

Trailing P/E5Y Low

8.2x

Forward P/E

10.8x

EV/EBITDA0th %ile

4.5x

FCF YieldCash Flow

13.4%

Valuation vs 5-Year History

Multiple Range

Metric

Current

5Y Median

Historical Range

Percentile

P/E

8.2x

18.1x

0th· Low

EV/EBITDA

4.5x

5.9x

0th· Low

Price/FCF

7.4x

14.5x

0th· Low

Current Multiple

5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection

No DCF Model AvailableIntrinsic value modeling is not supported for this equity.

Growth & profitability

Annual revenue & EPS trend

Revenue

$229M+14.2% YoY

Net income

$10M+233.8% YoY

Free cash flow

$11M+5.6% YoY

Operating margin

5.3%+3.2 pts YoY

ROIC (TTM)37.5%

Avg ROIC 5Y-

ROE (TTM)32.3%

Piotroski Score7 / 9

Financial Statements →

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History

EPS Beat Rate5/12 (45%)

Revenue Beat Rate3/12 (25%)

Quarter	EPS (Act vs Est)	Revenue (Act vs Est)
Q3 2026Latest Aug 27, 2026	$0.11-4.3% vs $0.12	$42M-3.7% vs $44M
Q2 2026 May 6, 2026	$0.12-25.0% vs $0.16	$44M-8.5% vs $48M
Q1 2026 Feb 4, 2026	$0.15-21.1% vs $0.19	$49M-10.1% vs $54M
Q4 2025 Nov 4, 2025	$0.18+5.9% vs $0.17	$58M+7.4% vs $54M

Historical baseline: 12 quarters analyzedGAAP / Adjusted

MARKET COVERAGE

Latest News

5 Stories

GlobeNewsWire·6d ago

LifeVantage to Participate in the WTR Virtual Insights Conference on Wednesday, September 23, 2026

SALT LAKE CITY, Sept. 18, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Terrence Moorehead, Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the upcoming WTR Virtual Insights Conference on Wednesday, September 23, 2026.

Seeking Alpha·Aug 27, 2026

LifeVantage Corporation (LFVN) Q4 2026 Earnings Call Transcript

MarketBeat·Aug 27, 2026

Lifevantage Q4 Earnings Call Highlights

Lifevantage NASDAQ: LFVN reported lower fourth-quarter and fiscal 2026 results as the health and wellness company faced fewer orders, lower average order sizes and a difficult comparison against prior-year sales of its MindBody GLP-1 System.

GlobeNewsWire·Aug 27, 2026

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026

SALT LAKE CITY, Aug. 27, 2026 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth fiscal quarter ended June 30, 2026.

Filtered for LifeVantage CorporationMore Headlines

Compare before deciding

Benchmark LFVN against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for LifeVantage Corporation (LFVN)

Full Screener →

Company	Price	Market Cap	P/E Ratio	Rev Growth (1Y)	Net Margin	ROE	Div Yield
LFVNLifeVantage CorporationCurrent	$6.20	$78.22M	8.16	14.17%	4.29%	32.34%	2.57%
NATRNature's Sunshine Products, Inc.	$12.95	$227.72M	12.22	5.67%	3.68%	10.89%	—
NHTCNatural Health Trends Corp.	$1.05	$10.95M	-13.69	-7.42%	-4.51%	-8%	—
QNSTQuinStreet, Inc.	$14.28	$820.32M	176.95	78.27%	6.28%	27.66%	—
HLFHerbalife Nutrition Ltd.	$11.99	$1.24B	5.45	0.89%	3.16%	—	—
USNAUSANA Health Sciences, Inc.	$14.04	$259.22M	24.21	8.28%	-2.43%	-3.8%	—

Compare LFVN vs Peers

LifeVantage Corporation (LFVN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NATR

Most directly comparable listed peer for LFVN.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare LFVN against a more recognizable public peer.

Peer Set

Compare Top 5

vs NATR, NHTC, QNST, HLF

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

LFVN SEC Filings & Documents

LifeVantage Corporation (LFVN) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Aug 27, 2026·SEC

Material company update

Aug 3, 2026·SEC

Material company update

May 6, 2026·SEC

10-K Annual Reports

FY 2026

Aug 27, 2026·SEC

FY 2025

Sep 4, 2025·SEC

FY 2024

Aug 28, 2024·SEC

10-Q Quarterly Reports

FY 2026

May 6, 2026·SEC

FY 2026

Feb 4, 2026·SEC

FY 2025

Nov 4, 2025·SEC

Get notified when LFVN posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

LFVN Frequently Asked Questions

LifeVantage Corporation (LFVN) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

What is LifeVantage Corporation's revenue?

LifeVantage Corporation (LFVN) reported $182.6M in revenue for fiscal year 2025.

How fast is LifeVantage Corporation growing?

LifeVantage Corporation (LFVN) grew revenue by 14.2% over the past year. This is steady growth.

Is LFVN profitable?

Yes, LifeVantage Corporation (LFVN) is profitable, generating $5.1M in net income for fiscal year 2025 (4.3% net margin).

Dividend & Returns

Does LFVN pay dividends?

Yes, LifeVantage Corporation (LFVN) pays a dividend with a yield of 2.57%. This makes it attractive for income-focused investors.

What is LFVN's return on equity?

LifeVantage Corporation (LFVN) has a return on equity (ROE) of 32.3%. This is excellent, indicating efficient use of shareholder capital.

What is LifeVantage Corporation's free cash flow?

LifeVantage Corporation (LFVN) generated $6.7M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in LFVN back in 1997?

Total return calculator · dividends reinvested · 29+ years of data

See returns →

Quarter

EPS (Act vs Est)

Revenue (Act vs Est)

Q3 2026Latest

Aug 27, 2026

$0.11-4.3%

vs $0.12

$42M-3.7%

vs $44M

Q2 2026

May 6, 2026

$0.12-25.0%

vs $0.16

$44M-8.5%

vs $48M

Q1 2026

Feb 4, 2026

$0.15-21.1%

vs $0.19

$49M-10.1%

vs $54M

Q4 2025

Nov 4, 2025

$0.18+5.9%

vs $0.17

$58M+7.4%

vs $54M

Company

Price

Market Cap

P/E Ratio

Rev Growth (1Y)

Net Margin

ROE

Div Yield

LFVNLifeVantage CorporationCurrent

$6.20

$78.22M

8.16

14.17%

4.29%

32.34%

2.57%

NATRNature's Sunshine Products, Inc.

$12.95

$227.72M

12.22

5.67%

3.68%

10.89%

—

NHTCNatural Health Trends Corp.

$1.05

$10.95M

-13.69

-7.42%

-4.51%

-8%

—

QNSTQuinStreet, Inc.

$14.28

$820.32M

176.95

78.27%

6.28%

27.66%

—

HLFHerbalife Nutrition Ltd.

$11.99

$1.24B

5.45

0.89%

3.16%

—

USNAUSANA Health Sciences, Inc.

$14.04

$259.22M

24.21

8.28%

-2.43%

-3.8%

—